US FDA authorises 2nd dose of updated Covid booster for older adults

Los Angeles, April 19 The US Food and Drug Administration (FDA) has amended the emergency use authorisations of the Moderna and Pfizer-BioNTech Covid-19 bivalent mRNA vaccines, approving a second dose of the updated Covid-19 booster for older adults and people with weakened immune systems.

Those 65 and older can get a second dose of the updated versions of the Moderna and Pfizer-BioNTech booster at least four months following their initial bivalent dose, Xinhua news agency reported, citing a statement by the FDA.

Most people who are immunocompromised can get an additional updated booster dose at least two months following their last dose, according to the FDA.

Most unvaccinated individuals may receive a single dose of a bivalent vaccine, rather than multiple doses of the original monovalent mRNA vaccines.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor